Advertisement
Advertisement
U.S. markets open in 5 hours 37 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Lineage Cell Therapeutics, Inc. (LCTX)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.3400+0.0100 (+0.43%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close2.3300
Open2.3400
Bid0.0000 x 2900
Ask0.0000 x 3000
Day's Range2.2900 - 2.3700
52 Week Range1.0100 - 3.1300
Volume537,333
Avg. Volume648,229
Market Cap391.856M
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)-0.0780
Earnings DateNov 02, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LCTX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lineage Cell Therapeutics, Inc.
    Analyst Report: Baxter International Inc.Based in Deerfield, Illinois, Baxter International provides critical care, nutrition, renal, hospital, and surgical products. Baxter has approximately 50,000 employees and manufacturing operations in more than 20 countries. It is also a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
Advertisement
Advertisement